Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Measles are back. This tool calculates the exact cost to our economy

The measles are back, and the outbreak isn’t just costing Americans their health. The surge is also costing the U.S. economy millions . In 2025, the United States experienced the largest number of measles cases since its elimination in 2000 26 years ago. A drop in vaccines rates has led to a resurgence of the disease, which has roared back with over 5,182 cases reported in 2026 alone as of early…

Measles are back. This tool calculates the exact cost to our economy

Measles cases are on the rise in the United States, with a new tool from John Hopkins University revealing the staggering economic impact of the outbreak. In 2025, the U.S. reported its largest number of measles cases since elimination in 2000, with over 5,182 cases confirmed as of early November according to the Centers for Disease Control and Prevention (CDC).

Pennsylvania has been particularly hard hit, with six deaths linked to the disease. The 2025 measles outbreak has cost nearly $83 million, including $56 million for public health response efforts, $25 million in lost productivity, and over $1.8 million in medical expenses. The tool estimates that even small outbreaks incur significant costs, with about $250,000 required to respond initially, regardless of the number of cases, plus roughly $16,300 per additional case.

The U.S. is expected to lose its measles elimination status, which is currently under review by the Pan American Health Organization (PAHO). Measles is a highly contagious viral disease that can be dangerous, especially for infants and young children. It spreads through the air when an infected person coughs or sneezes, and about 9 out of 10 unvaccinated individuals exposed to the virus will contract it in the following two hours.

Written by urgent.news from Fast Company's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at fastcompany.com →

More in Health & Medicine

More from Wednesday 11 November →